Inflammation, inflammatory cells and angiogenesis: Decisions and indecisions

Douglas M. Noonan, Andrea De Lerma Barbaro, Nicola Vannini, Lorenzo Mortara, Adriana Albini

Research output: Contribution to journalArticle

184 Citations (Scopus)

Abstract

Endothelial-immune cell cross-talk goes well beyond leukocyte and lymphocyte trafficking, since immune cells are able to intimately regulate vessel formation and function. Here we review the evidence that most immune cells are capable of polarization towards a dichotomous activity either inducing or inhibiting angiogenesis. In addition to the well-known roles of tumor associated macrophages, we find that neutrophils, myeloid-derived suppressor and dendritic cells clearly have the potential for influencing tumor angiogenesis. Further, the physiological functions of NK cells suggest that these cells may also show a potentially important role in pro- or anti-angiogenesis regulation within the tumor microenvironment. At the same time many angiogenic factors influence the activity and function of immune cells that generally favor tumor survival and tolerance. Thus the immune system itself represents a major pharmaceutical target and links angiogenesis inhibition to immunotherapy.

Original languageEnglish
Pages (from-to)31-40
Number of pages10
JournalCANCER AND METASTASIS REVIEW
Volume27
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Inflammation
Neoplasms
Tumor Microenvironment
Angiogenesis Inducing Agents
Natural Killer Cells
Immunotherapy
Dendritic Cells
Immune System
Neutrophils
Leukocytes
Endothelial Cells
Macrophages
Lymphocytes
Pharmaceutical Preparations
Myeloid-Derived Suppressor Cells

Keywords

  • Angiogenesis
  • Cardiovasculature
  • Immune cells
  • Inflammation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Inflammation, inflammatory cells and angiogenesis : Decisions and indecisions. / Noonan, Douglas M.; De Lerma Barbaro, Andrea; Vannini, Nicola; Mortara, Lorenzo; Albini, Adriana.

In: CANCER AND METASTASIS REVIEW, Vol. 27, No. 1, 03.2008, p. 31-40.

Research output: Contribution to journalArticle

Noonan, Douglas M. ; De Lerma Barbaro, Andrea ; Vannini, Nicola ; Mortara, Lorenzo ; Albini, Adriana. / Inflammation, inflammatory cells and angiogenesis : Decisions and indecisions. In: CANCER AND METASTASIS REVIEW. 2008 ; Vol. 27, No. 1. pp. 31-40.
@article{60cce4c3537d401fb5b11ccc0d9e1cac,
title = "Inflammation, inflammatory cells and angiogenesis: Decisions and indecisions",
abstract = "Endothelial-immune cell cross-talk goes well beyond leukocyte and lymphocyte trafficking, since immune cells are able to intimately regulate vessel formation and function. Here we review the evidence that most immune cells are capable of polarization towards a dichotomous activity either inducing or inhibiting angiogenesis. In addition to the well-known roles of tumor associated macrophages, we find that neutrophils, myeloid-derived suppressor and dendritic cells clearly have the potential for influencing tumor angiogenesis. Further, the physiological functions of NK cells suggest that these cells may also show a potentially important role in pro- or anti-angiogenesis regulation within the tumor microenvironment. At the same time many angiogenic factors influence the activity and function of immune cells that generally favor tumor survival and tolerance. Thus the immune system itself represents a major pharmaceutical target and links angiogenesis inhibition to immunotherapy.",
keywords = "Angiogenesis, Cardiovasculature, Immune cells, Inflammation",
author = "Noonan, {Douglas M.} and {De Lerma Barbaro}, Andrea and Nicola Vannini and Lorenzo Mortara and Adriana Albini",
year = "2008",
month = "3",
doi = "10.1007/s10555-007-9108-5",
language = "English",
volume = "27",
pages = "31--40",
journal = "Cancer and Metastasis Reviews",
issn = "0167-7659",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Inflammation, inflammatory cells and angiogenesis

T2 - Decisions and indecisions

AU - Noonan, Douglas M.

AU - De Lerma Barbaro, Andrea

AU - Vannini, Nicola

AU - Mortara, Lorenzo

AU - Albini, Adriana

PY - 2008/3

Y1 - 2008/3

N2 - Endothelial-immune cell cross-talk goes well beyond leukocyte and lymphocyte trafficking, since immune cells are able to intimately regulate vessel formation and function. Here we review the evidence that most immune cells are capable of polarization towards a dichotomous activity either inducing or inhibiting angiogenesis. In addition to the well-known roles of tumor associated macrophages, we find that neutrophils, myeloid-derived suppressor and dendritic cells clearly have the potential for influencing tumor angiogenesis. Further, the physiological functions of NK cells suggest that these cells may also show a potentially important role in pro- or anti-angiogenesis regulation within the tumor microenvironment. At the same time many angiogenic factors influence the activity and function of immune cells that generally favor tumor survival and tolerance. Thus the immune system itself represents a major pharmaceutical target and links angiogenesis inhibition to immunotherapy.

AB - Endothelial-immune cell cross-talk goes well beyond leukocyte and lymphocyte trafficking, since immune cells are able to intimately regulate vessel formation and function. Here we review the evidence that most immune cells are capable of polarization towards a dichotomous activity either inducing or inhibiting angiogenesis. In addition to the well-known roles of tumor associated macrophages, we find that neutrophils, myeloid-derived suppressor and dendritic cells clearly have the potential for influencing tumor angiogenesis. Further, the physiological functions of NK cells suggest that these cells may also show a potentially important role in pro- or anti-angiogenesis regulation within the tumor microenvironment. At the same time many angiogenic factors influence the activity and function of immune cells that generally favor tumor survival and tolerance. Thus the immune system itself represents a major pharmaceutical target and links angiogenesis inhibition to immunotherapy.

KW - Angiogenesis

KW - Cardiovasculature

KW - Immune cells

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=38549162640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549162640&partnerID=8YFLogxK

U2 - 10.1007/s10555-007-9108-5

DO - 10.1007/s10555-007-9108-5

M3 - Article

C2 - 18087678

AN - SCOPUS:38549162640

VL - 27

SP - 31

EP - 40

JO - Cancer and Metastasis Reviews

JF - Cancer and Metastasis Reviews

SN - 0167-7659

IS - 1

ER -